Oncology World Thrombosis Day at 10, talking blood clots and cancer A new 'Move Against Thrombosis' campaign and discussion of cancer-related blood clotting.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
Oncology Pfizer’s bispecific elranatamab and future oncological care Pfizer announced that the FDA granted Priority Review for its BLA for bispecific elranatamab.
Oncology Time to level the playing field for men with prostate cancer Prostate cancer affects not just patients, but their families too.
Oncology Could cancer be the next mRNA breakthrough? mRNA vaccines achieved their first success against COVID-19, but could a cancer target be next?
Oncology Optimised cancer drug dosing - FDA guidelines’ quantum leap Dose optimisation guidance for clinical trials was released by the FDA this January.
News Biogen, Ionis trumpet Alzheimer's data, but shares dip Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
